Mark L Saxton

Title: Mark L Saxton: Innovator in Tumor Treatment

Introduction

Mark L Saxton is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of immunotherapy, particularly in methods for treating tumors. His innovative approach focuses on enhancing the antitumor activity of immune cells.

Latest Patents

Mark L Saxton holds a patent for a method of treating tumors with CD8.sup.+ -depleted or CD4.sup.+ T cells. This invention provides a method for enhancing the immunotherapeutic activity of immune cells by depleting a cell subset that down-regulates the immune response. The remaining immune cell population is cultured in the presence of an antibody to a lymphocyte surface receptor, preferably an anti-CD3 monoclonal antibody, optionally with interleukin-2. This method also includes administering the stimulated immune cell population to a mammal with tumors, along with an immunosuppressant and liposomal IL-2.

Career Highlights

Throughout his career, Mark L Saxton has worked with esteemed organizations, including the United States of America as represented by the Department of Health and The Regents of the University of Minnesota. His work has contributed to advancements in cancer treatment and immunotherapy.

Collaborations

Mark has collaborated with notable professionals in his field, including Augusto C Ochoa and Dan L Longo. These collaborations have furthered research and development in immunotherapeutic methods.

Conclusion

Mark L Saxton's innovative work in tumor treatment exemplifies the potential of immunotherapy in modern medicine. His contributions continue to influence the field and offer hope for improved cancer treatments.